BioPharm International
January 01, 2010
Issue PDF
23
1
Biopharma Navigates Stormy Seas
January 01, 2010
Regulatory Beat
23
1
How will implementing Quality by Design strategies affect your compliance status?
January 01, 2010
Regulatory Beat
23
1
Demand for new vaccines and therapies in 2010 will be offset by concerns about drug prices and product safety.
January 01, 2010
Perspectives on Outsourcing
23
1
A systematic classification system makes supplier quality management feasible, even if you are dealing with hundreds of suppliers worldwide.
January 01, 2010
Final Word
23
1
The nimbleness of biotechs makes them well suited to implementing QbD. Here's how to get started.
January 01, 2010
Burrill on Biotech
23
1
The companies that have survived the financial meltdown are well placed to adapt to the new environment that we now are entering.
January 01, 2010
Manufacturing Economics Series
23
1
Regulatory flexibility can make continuous improvement possible.
January 01, 2010
Cover
23
1
The year 2009 was marked by recession, industry megamergers, and venture-capital scarcity. How did biopharmaceutical professionals fare?
January 01, 2010
From the Editor
23
1
QbD has always embraced the notion that companies could make certain process changes without regulatory oversight.
January 01, 2010
Features
23
1
Key considerations for defining your overall control strategy.